miR-139-5p Represses BMSC Osteogenesis via Targeting Wnt/β-Catenin Signaling Pathway

miR-139-5p Represses BMSC Osteogenesis via Targeting Wnt/β-Catenin Signaling Pathway
复制标题

miR-139-5p 通过靶向 Wnt/β-Catenin 信号通路抑制 BMSC 成骨

DOI:
10.1089/dna.2017.3657
复制
发表时间:
2017-08-01
影响因子:
3.1
通讯作者:
Zhu, Jianxi
Zhu, Jianxi
中科院分区:
生物学4区
文献类型:
--
作者:
Long, Haitao;Sun, Buhua;Zhu, Jianxi

文献摘要

被引文献

相似文献

间充质干细胞(MSC)的成骨作用在骨修复中发挥着必要的作用。根据一些报道,microRNA参与细胞的不同生理活动,包括细胞分化。本研究探讨miR-139- 5 p在人骨髓间充质干细胞(hBMSCs)成骨分化中的作用。除了miR-139- 5 p之外,还研究了碱性磷酸酶(ALP)的作用,ALP是一种被认为是早期成骨分化标志物的膜结合金属酶。富钙存款(矿化)也是一个典型的成骨分化标志物,可以通过茜素红S(ARS)染色可视化。抑制miR-139- 5 p显著促进hBMSC成骨细胞分化,然而,过表达的miR-139- 5 p将降低hBMSC成骨细胞分化。这一结果是基于ALP活性、ARS染色以及成骨基因表达的变化,包括Runx 2、胶原I和骨钙素。miR-139- 5 p通过直接靶向Wnt/beta-catenin通路的关键因子CTNNB 1和Frizzled 4(FZD 4),在BMSC成骨中发挥作用。总之,根据本研究,抑制miR-139- 5 p可能是hBMSC成骨中有前途的策略。
Osteogenesis of mesenchymal stem cells (MSCs) has played a necessary role in the repair of bone. According to some reports, microRNAs participate in different physiological activity of the cells, including cell differentiation. This study investigated the function that miR-139-5p plays in the osteogenic differentiation of human bone marrow MSCs (hBMSCs). In addition to miR-139-5p, the effects of alkaline phosphatase (ALP), a membrane-bound metalloenzyme that is considered an early osteogenic differentiation marker, have also been investigated. Calcium-rich deposit (mineralization) is also a typical osteogenic differentiation marker that could be visualized by alizarin red S (ARS) staining. Inhibiting miR-139-5p notably promotes the hBMSC osteoblast differentiation, which, however, will be reduced by overexpressed miR-139-5p. This result has been made based on the alternations of ALP activity, ARS staining, as well as expression of osteogenic genes, including runt-related gene-2 (Runx2), collagen I (Col-1), and osteocalcin (OCN). miR-139-5p exerts its role in BMSC osteogenesis most probably through the Wnt/beta-catenin pathway, by direct targeting CTNNB1 and frizzled 4 (FZD4), essential factors of Wnt/beta-catenin pathway. In conclusion, according to the present study, inhibiting miR-139-5p could be a promising strategy in hBMSC osteogenesis.